These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3540254)

  • 1. Biological indicators in the pharmaceutical and the medical device industry.
    Pflug IJ; Odlaug TE
    J Parenter Sci Technol; 1986; 40(5):242-8. PubMed ID: 3540254
    [No Abstract]   [Full Text] [Related]  

  • 2. Panel discussion: environmental sampling in an aseptic environment. I. Microbiological environmental monitoring.
    Raiman HL
    Bull Parenter Drug Assoc; 1974; 28(6):253-60. PubMed ID: 4616742
    [No Abstract]   [Full Text] [Related]  

  • 3. The 1993 Medical Device Technology sterilization survey.
    Pearson LS
    Med Device Technol; 1993 May; 4(4):42-6. PubMed ID: 10148576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and routine operation of a sterile dry powder filling facility.
    Prout G
    J Parenter Sci Technol; 1982; 36(5):199-204. PubMed ID: 6927748
    [No Abstract]   [Full Text] [Related]  

  • 5. [The safety of a steam sterilization process using Thermalog-S indicators in the field of pharmaceutics].
    Franchi G; Lencioni E
    Boll Chim Farm; 1978 Oct; 117(10):620-6. PubMed ID: 743357
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical Device Technology sterilization survey.
    Sash Pearson L
    Med Device Technol; 1996 Mar; 7(2):58-64. PubMed ID: 10159870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative terminal sterilization.
    Lindboe WG; Hayakawa K
    J Parenter Sci Technol; 1993; 47(3):138-41. PubMed ID: 8360807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microbiological in-process control in drug manufacture].
    Seyfarth VH
    Arzneimittelforschung; 1985; 35(1A):205-16. PubMed ID: 4039162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid/automated ID methods survey. PDA Microbial ID Task Force. Parenteral Drug Association.
    J Parenter Sci Technol; 1990; 44(4):216-22. PubMed ID: 2213430
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cleaning of machines for pharmaceutical production: microbiological investigation to establish validation procedures].
    Anastasio P; Carazzone M; Genova R; Malesani L; Molinari ML
    Boll Chim Farm; 1987 Mar; 126(3):116-20. PubMed ID: 3689577
    [No Abstract]   [Full Text] [Related]  

  • 11. An approach to establishing parenteral solution sterilization cycles.
    Korczynski MS; Peterson CL; Loshbaugh CC
    Bull Parenter Drug Assoc; 1974; 28(6):270-7. PubMed ID: 4455323
    [No Abstract]   [Full Text] [Related]  

  • 12. [Flow of laminar air: use in sterile rooms].
    Lumini E
    Boll Chim Farm; 1975 Jul; 114(7):361-74. PubMed ID: 1164445
    [No Abstract]   [Full Text] [Related]  

  • 13. Microbial identification strategies in the pharmaceutical industry.
    Cundell AM
    PDA J Pharm Sci Technol; 2006; 60(2):111-23. PubMed ID: 16696194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filling vials aseptically while monitoring for bacterial contamination.
    Dirksen JW; Larsen RV
    Am J Hosp Pharm; 1975 Oct; 32(10):1031-2. PubMed ID: 1190216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Control of the efficacy of sterility protectors].
    Bernard J; Desvignes A
    Ann Pharm Fr; 1983; 41(2):185-92. PubMed ID: 6651167
    [No Abstract]   [Full Text] [Related]  

  • 16. [The microbiology of medication: concept - elaboration - control].
    Lagodsky H; Blanchard JC; Jandard M; Migne J
    Biol Med (1971); 1973 Dec; 2(2):141-56. PubMed ID: 4807318
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bioengineering, pharmaceutical development and control of contamination: the three components of pharmaceutical engineering and their influence in advanced methods of production].
    Ghirardini M; Falini R
    Boll Chim Farm; 1986 Sep; 125(9):328-38. PubMed ID: 3828099
    [No Abstract]   [Full Text] [Related]  

  • 18. Panel discussion: Environmental sampling in an aseptic environment. III. Cross contamination control.
    Elias WF
    Bull Parenter Drug Assoc; 1974; 28(6):263-9. PubMed ID: 4455322
    [No Abstract]   [Full Text] [Related]  

  • 19. How to respond to changes in the regulation of the ethylene-oxide sterilisation process.
    Young WT
    Med Device Technol; 2006 Apr; 17(3):12-5. PubMed ID: 16736657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiation as a microbiological contamination control of drugs, cosmetics and medical devices].
    Ishizeki C
    Radioisotopes; 1985 May; 34(5):282-91. PubMed ID: 3898238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.